Metformin | ||||
| Egyptian Pharmaceutical Journal | ||||
| Volume 19, Issue 2, April 2020, Page 81-86 PDF (377.89 K) | ||||
| DOI: 10.4103/epj.epj_50_19 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mohammad Asif; Mrityunjoy Acharya; Mohd Imran | ||||
| Abstract | ||||
At present metformin is the core for the management of type-2 diabetes mellitus. The key clue of metformin as a hypoglycemic drug was collected from the traditional utilization of for the management of diabetes. Modern study recommends several valuable activities of Metformin other than the hypoglycemic effect such as type-1 diabetes mellitus, polycystic ovary syndrome, cholesterol-lowering effect, avoidance of heart disease, age, cancer, and neuroprotection. In the present review, we are discussing about the source and versatile utilization of metformin and its outcome. | ||||
| Keywords | ||||
| Cancer; Diabetes mellitus; Metformin; neuroprotective; polycystic ovary syndrome; Traditional use; Type-1 Diabetes Mellitus; Type-2 diabetes mellitus | ||||
|
Statistics Article View: 57 PDF Download: 29 |
||||
